Analyst
Morgan Stanley
Equibles does not estimate personal net worth.
Sean Laaman is recorded as Analyst at Morgan Stanley. Sean Laaman has spoken on 4 earnings calls across 2 companies, most recently for Acadia Pharmaceuticals Inc on February 25, 2026. Those appearances were for Resmed Inc (RMD) and Acadia Pharmaceuticals Inc (ACAD). The companies whose calls Sean Laaman spoke on are classified in the Healthcare sector.
“Good afternoon Catherine and team, hope everyone's well and thank you for taking my question.”
“Mick, my question relates to the commonality between components of the various devices. Is there a lot of commonality between the AirSense 10 and AirSense 11 platforms.”
“I have a question on the exit of the POC business. If I get this right, and I think I've got it simplistically right, but please correct me: you think you've got those mid-stage COPD patients covered already through non-invasive ventilation and there's better reimbursement and maybe better clinical outcomes.”
“I'd like to just ask about the sustainability and that suppression in SG&A growth. It seems like a very good outcome. If you could talk us through that? I know we've got guidance for fiscal '21, but if you could talk us through that, that would be really useful, Mick.”
Morgan Stanley
Analyst
Source not stated
RMD
Medical Instruments & Supplies · Healthcare
